Proteome analysis of cerebrospinal fluid in healthy beagles and canine encephalitis

Journal of Veterinary Medical Science

Volumn 74, Issue 6, 2012, Pages 751-756

  Nakamura, Kozo ^a   Miyasho, Taku ^a   Nomura, Sachiko ^a   Yokota, Hiroshi ^a   Nakade, Tetsuya ^a  

^a RAKUNO GAKUEN UNIVERSITY   (Japan)

Author keywords

2DE; Canine; CSF; Encephalitis; Proteome

Indexed keywords

BIOLOGICAL MARKER; ENOLASE; PROTEOME;

ANIMAL; ANIMAL DISEASE; ARTICLE; CEREBROSPINAL FLUID; DOG; DOG DISEASE; GENETICS; IMMUNOBLOTTING; ISOLATION AND PURIFICATION; MASS SPECTROMETRY; MENINGOENCEPHALITIS; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANIMALS; BIOLOGICAL MARKERS; DOG DISEASES; DOGS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; IMMUNOBLOTTING; MENINGOENCEPHALITIS; PHOSPHOPYRUVATE HYDRATASE; PROTEOME; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

CANIS FAMILIARIS;

EID: 84863808515     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.11-0474     Document Type: Article

References (19)

1. Bai, S., Liu, S., Guo, X., Qin, Z., Wang, B., Li, X., Qin, Y. and Liu, Y. H. 2009. Proteome analysis of biomarkers in the cerebrospinal fluid of neuromyelitis optica patients. Mol. Vis. 15: 1638-1648. [Medline]
2. Brenn, A., Karger, A., Skiba, M., Ziegler, U. and Groschup, M. H. 2009. A comprehensive proteome map of bovine cerebrospinal fluid. Proteomics 9: 5199-5205. [Medline] [CrossRef]
3. Carney, D. N., Marangos, P. J., Ihde, D. C., Bunn, P. A. Jr., Cohen, M. H., Minna, J. D. and Gazdar, A. F. 1982. Serum neuron-specific enolase: a marker for disease extent and response to therapy of small-cell lung cancer. Lancet 1: 583-585. [Medline]
4. Castaño, E. M., Roher, A. E., Esh, C. L., Kokjohn, T. A. and Beach, T. 2006. Comparative proteomics of cerebrospinal fluid in neuropathologically confirmed Alzheimer's disease and non-demented elderly subjects. Neurol. Res. 28: 155-163. [Medline] [CrossRef]
5. D'Aguanno, S., Barassi, A., Lupisella, S., D'eril, G. M., Del Bocci, P., Pieragostino, D., Pallotti, F., Carelli, V., Valentino, M. L., Liguori, R., Avoni, P., Bernardini, S., Gambi, D., Urbani, A. and Federici, G. 2008. Differential cerebro spinal fluid proteome investigation of Leber hereditary optic neuropathy (LHON) and multiple sclerosis. J. Neuroimmunol. 193: 156-160. [Medline] [CrossRef]
6. Dauberschmidt, R., Marangos, P. J., Zinsmeyer, J., Bender, V., Klages, G. and Gross, J. 1983. Severe head trauma and the changes of concentration of neuron-specific enolase in plasma and in cerebrospinal fluid. Clin. Chim. Acta 131: 165-170. [Medline] [CrossRef]
7. Finehout, E. J., Franck, Z. and Lee, K. H. 2004. Towards twodimensional electrophoresis mapping of the cerebrospinal fluid proteome from a single individual. Electrophoresis 25: 2564-2575. [Medline] [CrossRef]
8. Goldman, D., Merril, C. R. and Ebert, M. H. 1980. Two-dimensional gel electrophoresis of cerebrospinal fluid proteins. Clin. Chem. 26: 1317-1322. [Medline]
9. Hashimoto, K., Gotoh, Y. and Tada, K. 1986. Serum neuronspecific enolase as a marker useful for monitoring the effectiveness of therapy in patients with neuroblastoma-as compared with urinary catecholamine metabolites. Tohoku J. Exp. Med. 149: 25-30. [Medline] [CrossRef]
10. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685. [Medline] [CrossRef]
11. Lehmensiek, V., Süssmuth, S. D., Brettschneider, J., Tauscher, G., Felk, S., Gillardon, F. and Tumani, H. 2007. Proteome analysis of cerebrospinal fluid in Guillain-Barré syndrome (GBS). J. Neuroimmunol. 185: 190-194. [Medline] [CrossRef]
12. Oishi, S. and Sato, T. 1988. Elevated serum neuron-specific enolase in patients with malignant pheochromocytoma. Cancer 61: 1167-1170. [Medline] [CrossRef]
13. Pouw, M. H., Hosman, A. J., van Middendorp, J. J., Verbeek, M. M., Vos, P. E. and van de Meent, H. 2009. Biomarkers in spinal cord injury. Spinal Cord 47: 519-525. [Medline] [CrossRef]
14. Satoh, H., Yamato, O., Asano, T., Yonemura, M., Yamauchi, T., Hasegawa, D., Orima, H., Arai, T., Yamasaki, M. and Maede, Y. 2007. Cerebrospinal fluid biomarkers showing neurodegeneration in dogs with GM1 gangliosidosis: possible use for assessment of a therapeutic regimen. Brain Res. 1133: 200-208. [Medline] [CrossRef]
15. Selaković, V. 2003. Neuron-specific enolase in cerebrospinal fluid and plasma of patients with acute ischemic brain disease. Med. Pregl. 56: 326-332. [Medline] [CrossRef]
16. Yang, Y., Liu, S., Qin, Z., Cui, Y., Qin, Y. and Bai, S. 2009. Alteration of cystatin C levels in cerebrospinal fluid of patients with Guillain-Barré Syndrome by a proteomical approach. Mol. Biol. Rep. 36: 677-682. [Medline] [CrossRef]
17. Yang, Y. R., Liu, S. L., Qin, Z. Y., Liu, F. J., Qin, Y. J., Bai, S. M. and Chen, Z. Y. 2008. Comparative proteomics analysis of cerebrospinal fluid of patients with Guillain-Barré syndrome. Cell. Mol. Neurobiol. 28: 737-744. [Medline] [CrossRef]
18. van Engelen, B. G., Lamers, K. J., Gabreels, F. J., Wevers, R. A., van Geel, W. J. and Borm, G. F. 1992. Age-related changes of neuron-specific enolase, S-100 protein, and myelin basic protein concentrations in cerebrospinal fluid. Clin. Chem. 38: 813-816.[Medline]
19. Zarfoss, M., Schatzberg, S., Venator, K., Cutter-Schatzberg, K., Cuddon, P., Pintar, J., Weinkle, T., Scarlett, J. and Delahunta, A. 2006. Combined cytosine arabinoside and prednisone therapy for meningoencephalitis of unknown aetiology in 10 dogs. J. Small Anim. Pract. 47: 588-595. [Medline] [CrossRef]